Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 3 2Phase NA 1

Status

Unknown 4Completed 1

Sponsor Class

OTHER 733INDUSTRY 210NIH 58NETWORK 56OTHER_GOV 15UNKNOWN 5FED 2

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 2Breast 2Sarcoma 1

Conditions

Stomach Neoplasms 2Sarcoma 1Breast Neoplasms 1Breast Cancer Recurrent 1

Interventions

S 1 (combination) 12Capecitabine 11Paclitaxel 9Cisplatin 9apatinib 8Oxaliplatin 8pyrotinib 6nimotuzumab 6130-nm albumin-bound paclitaxel 6titanium silicide 5sintilimab 5camrelizumab 5anlotinib 5Etoposide 5Docetaxel 5Carboplatin 5Trastuzumab 4Radiotherapy, Intensity-Modulated 4Irinotecan 4Bevacizumab 4Albumin-Bound Paclitaxel 4nedaplatin 3Vinorelbine 3Temozolomide 3Tegafur 3Taxes 3Radiosurgery 3Gemcitabine 3Fluorouracil 3Epirubicin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × UNKNOWN × Docetaxel × Clear all
NCT02725424 2022-08-17

MATCH

ChineseAMS

Phase 2 Completed
180 enrolled
Gastrointestinal

Stomach Neoplasms

NCT02947061 2016-10-31

S1 Plus Docetaxel Versus Capecitabine Plus Docetaxel First-line Treatment in Patients With Advanced Breast Cancer

ChineseAMS

Phase 2 Unknown
300 enrolled
Breast

Breast Cancer Recurrent

NCT01939054 2015-06-04

Nimotuzumab Plus Docetaxel and Capecitabine Versus Docetaxel and Capecitabine in the Treatment of Breast Cancer Patients

ChineseAMS

Phase 2 Unknown
90 enrolled
Breast

Breast Neoplasms

NCT01812018 2013-03-15

Endostar + GT in Pulmonary Metastases of Soft Tissue Sarcoma

ChineseAMS

Phase 2 Unknown
30 enrolled
Sarcoma

Sarcoma

NCT01747707 2012-12-12

Cisplatin,Docetaxel and S-1 for Advanced Gastric and Gastroesophageal Junction Cancer

ChineseAMS

Phase 2 Unknown
40 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡